Manufacturer profileAbbott Ireland Diagnostics Division, Lisnamuck, Longford, Co. Longford, Ireland
Albania28 devices registered in Albania1 risk classMar 04, 2021 – Mar 01, 2022
VerifiedAKBPM · official registry
28
Total devices
1
Risk classes
2021
Earliest registration
2022
Latest registration
Regulatory footprint
Search Abbott Ireland Diagnostics Division, Lisnamuck, Longford, Co. Longford, Ireland across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 10 Albania device registrations
Alkaline Phosphatase2
11389
Invitro · Mar 01, 2022
Total Bilirubin2
11388
Invitro · Mar 01, 2022
Lactate Dehydrogenase2
11332
Invitro · Feb 24, 2022
Total Bilirubin2
11331
Invitro · Feb 24, 2022
Alkaline Phosphatase2
11334
Invitro · Feb 24, 2022
Iron2: 04T0220; 04T0230
11333
Invitro · Feb 24, 2022
ARCHITECT Prolactin Reagent Kit
11020
Invitro · Jan 10, 2022
ARCHITECT Ferritin Reagent Kit
11030
Invitro · Jan 10, 2022
ARCHITECT FSH Reagent Kit
11025
Invitro · Jan 10, 2022
Creatinine2
11032
Invitro · Jan 10, 2022
Risk class distribution
Devices by risk class
Invitro28100.0% of total
About this profile
Explore comprehensive manufacturer profile for Abbott Ireland Diagnostics Division, Lisnamuck, Longford, Co. Longford, Ireland through Pure Global AI's free Albania medical device database. This company manufactures 28 medical devices registered in Albania across 1 risk class. Their registration history spans from Mar 04, 2021 to Mar 01, 2022.
This page provides detailed insights including recent registrations, risk class distribution (Invitro: 28), and complete regulatory information from the official Albania medical device database. Pure Global AI offers free access to Albania's complete medical device registry.